Physician profile
An Duy DO
NPI 1326392648
$7,700.39
in general payments reported to CMS, 2019-2025
26 companies · $742 in 2025
The $742 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,372 · 2020: $459 · 2021: $1,038 · 2022: $478 · 2023: $574 · 2024: $1,038 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,353.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,699.80 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $1,540.48 | 2019-2020 | |
| Vertiflex, INC. | $1,441.59 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $787.71 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $354.63 | 2019-2025 | Xtampza, Belbuca |
| Forte Bio-Pharma LLC | $337.45 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Boston Scientific Corporation | $258.99 | 2019-2025 | General - Pain Management |
| Painteq LLC | $208.58 | 2021 | |
| Stryker Corporation | $205.17 | 2024 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $167.97 | 2019-2025 | Ztlido |
| Vertos Medical, INC. | $142.86 | 2024 | Mild Device Kit |
| Arbor Pharmaceuticals, INC. | $108.11 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $63.94 | 2020-2021 | |
| Nalu Medical, INC. | $59.22 | 2022 | |
| Curonix LLC | $50.56 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Daiichi Sankyo INC. | $35.10 | 2019 | |
| Azurity Pharmaceuticals, INC. | $32.64 | 2023 | Horizant |
| Amgen INC. | $25.97 | 2019 | |
| Horizon Therapeutics Plc | $25.68 | 2021-2022 | |
| Masimo Corporation | $24.88 | 2023 | Patient Safetynet System |
| Spr Therapeutics, INC | $22.98 | 2022 | |
| Pfizer INC. | $16.88 | 2021 | |
| Elutia, INC. | $16.71 | 2019 | |
| Foundation Fusion Solutions, LLC | $15.74 | 2024-2025 | |
| Protega Pharmaceutials INC | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw An DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.